Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-03

Clinical Trial Update: Effects of Resveratrol in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effects of resveratrol in patients with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: Khoo Teck Puat Hospital | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED